HomeCompareELEAF vs JNJ

ELEAF vs JNJ: Dividend Comparison 2026

ELEAF yields 1.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELEAF wins by $22.44M in total portfolio value
10 years
ELEAF
ELEAF
● Live price
1.55%
Share price
$16.60
Annual div
$0.26
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.46M
Annual income
$19,980,387.57
Full ELEAF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ELEAF vs JNJ

📍 ELEAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELEAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELEAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELEAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELEAF
Annual income on $10K today (after 15% tax)
$131.82/yr
After 10yr DRIP, annual income (after tax)
$16,983,329.43/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ELEAF beats the other by $16,982,625.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELEAF + JNJ for your $10,000?

ELEAF: 50%JNJ: 50%
100% JNJ50/50100% ELEAF
Portfolio after 10yr
$11.24M
Annual income
$9,990,607.67/yr
Blended yield
88.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ELEAF
No analyst data
Altman Z
5.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELEAF buys
0
JNJ buys
0
No recent congressional trades found for ELEAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELEAFJNJ
Forward yield1.55%3.36%
Annual dividend / share$0.26$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$22.46M$20.0K
Annual income after 10y$19,980,387.57$827.78
Total dividends collected$22.24M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ELEAF vs JNJ ($10,000, DRIP)

YearELEAF PortfolioELEAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,010$310.16$10,676$355.77+$334.00ELEAF
2$12,419$638.29$11,407$389.39+$1.0KELEAF
3$14,634$1,345.75$12,198$426.53+$2.4KELEAF
4$18,623$2,964.08$13,056$467.62+$5.6KELEAF
5$26,977$7,050.33$13,987$513.12+$13.0KELEAF
6$47,955$19,089.75$14,998$563.56+$33.0KELEAF
7$114,741$63,429.35$16,098$619.52+$98.6KELEAF
8$406,449$283,676.34$17,295$681.69+$389.2KELEAF
9$2,313,166$1,878,265.82$18,599$750.82+$2.29MELEAF
10$22,455,476$19,980,387.57$20,022$827.78+$22.44MELEAF

ELEAF vs JNJ: Complete Analysis 2026

ELEAFStock

EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.

Full ELEAF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ELEAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELEAF vs SCHDELEAF vs JEPIELEAF vs OELEAF vs KOELEAF vs MAINELEAF vs ABBVELEAF vs MRKELEAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.